ARCL Organics appoints Deepak Daga as company secretary

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • ARCL Organics Ltd appoints Deepak Daga as Company Secretary and Compliance Officer
  • Appointment effective September 16, 2026, approved by the Board of Directors
  • Move ensures compliance with Companies Act 2013 and SEBI LODR regulations
  • Mr. Daga is an ICSI Associate Member with no shareholding or director relations
powered bylight_fuzz_icon
51082390

*this image is generated using AI for illustrative purposes only.

ARCL Organics Ltd appointed Deepak Daga as its Company Secretary and Compliance Officer effective September 16, 2026. The appointment was approved by the Board of Directors during a meeting held on the same date.

The decision aligns with Section 203 of the Companies Act, 2013 and Regulation 6 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Daga brings experience in corporate and secretarial matters to the role.

Appointment Details

Mr. Daga is an Associate Member of the Institute of Company Secretaries of India (ICSI), holding membership number 50346. He holds no shareholding in the company and has no relationship with any existing directors.

Particulars Details
Name Deepak Daga
Designation Company Secretary & Compliance Officer
Effective Date September 16, 2026
Shareholding Nil
Director Relationship None

The Board meeting commenced at 10:15 am and concluded at 10:45 am. The appointment follows a recommendation from the Nomination & Remuneration Committee. Terms and conditions for the role will be decided by the board.

Historical Stock Returns for ARCL Organics Ltd

1 Day5 Days1 Month6 Months1 Year5 Years
+5.00%+22.49%+16.54%+16.54%+16.54%+16.54%

How might Deepak Daga's appointment influence ARCL Organics' compliance strategy and regulatory risk management in the coming fiscal year?

What specific corporate governance initiatives or restructuring plans might the Board be preparing that necessitated this new compliance leadership?

Could this appointment signal upcoming strategic shifts, such as potential mergers, acquisitions, or IPO preparations for ARCL Organics?

ARCL Organics equity shares admitted to NSE permitted to trade

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Equity shares admitted to NSE permitted to trade category
  • Trading commenced on August 17, 2026
  • Company remains listed on BSE only
  • Filing made pursuant to SEBI LODR Regulation 30
powered bylight_fuzz_icon
50593413

*this image is generated using AI for illustrative purposes only.

ARCL Organics Limited equity shares have been admitted to dealings on the National Stock Exchange of India Limited (NSE) under the permitted to trade category. Trading commenced on August 17, 2026.

The company disclosed the development in a filing with the Bombay Stock Exchange (BSE) on September 10, 2026. The move follows a circular issued by the NSE listing department on August 14, 2026, notifying members of the admission.

Listing Details

The equity shares of ARCL Organics Limited are currently listed on the BSE only. The NSE admission is specifically for the permitted to trade segment, in compliance with applicable regulatory provisions.

Parameter Details
Company Name ARCL Organics Limited
Symbol ARCL
Exchange National Stock Exchange of India Limited
Category Permitted to Trade
Effective Date August 17, 2026
Face Value ₹10
Number of Securities 8,000,000
Market Lot 1

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rajesh Mundhra, Whole Time Director of the company, signed the filing.

Historical Stock Returns for ARCL Organics Ltd

1 Day5 Days1 Month6 Months1 Year5 Years
+5.00%+22.49%+16.54%+16.54%+16.54%+16.54%

What specific regulatory criteria must ARCL Organics meet to graduate from the 'Permitted to Trade' segment to the main board on the NSE?

How might the dual listing on BSE and NSE impact the stock's liquidity and price discovery mechanisms in the near term?

Are there any planned corporate actions, such as an FPO or rights issue, that could facilitate a full NSE listing in the coming quarters?

More News on ARCL Organics Ltd

1 Year Returns:+16.54%